Results 211 to 220 of about 53,857 (331)

Postpartum Depression: Overlap Between Symptom‐Based and Register‐Based Measures

Acta Psychiatrica Scandinavica, Volume 154, Issue 1, Page 50-59, July 2026.
ABSTRACT Introduction Postpartum depression (PPD) can be measured in various ways, including questionnaire‐based symptom scores or through administrative health databases. We examined the overlap between symptom‐based and register‐based PPD definitions and assessed the consistency in exposure‐outcome associations.
Sofie Egsgaard, Mette Bliddal, Mette‐Marie Zacher Kjeldsen, Xiaoqin Liu, Kathrine Bang Madsen, Merete Lund Mægbæk, Trine Munk‐Olsen   +6 more
wiley   +1 more source

Virtual reality and perioperative anxiety: a randomized controlled trial. [PDF]

Libyan J Med
Ouaz M, Mohamed Z, Issam K, Imen B, Hela A, Ali M.   +5 more
europepmc   +1 more source

Prescribing Patterns in Fatal Intoxications Involving Zopiclone and Alprazolam: An Observational Register‐Based Study

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 1, July 2026.
ABSTRACT Background Zopiclone was recently identified as a frequent contributor to fatal drug‐intoxications in Sweden. However, characteristics of misuse and factors associated with prescribed use remain insufficiently described. Alprazolam has a more established misuse profile. Objective The aim of the study was to describe and compare characteristics
Lova Tralla, Sara Gustavsson, Carl Söderberg, Anna K. Jönsson, Fredrik C. Kugelberg   +4 more
wiley   +1 more source

High prevalence of polypharmacy and nervous system medications in people with HIV: a cross-sectional analysis. [PDF]

Sci Rep
López López A, Pérez González A, Alonso Domínguez J, Ocampo A, Miralles C, Morano L, Aguayo Arjona J, Martínez López de Castro N, Poveda E.   +8 more
europepmc   +1 more source

Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT2A receptor agonists

British Journal of Pharmacology, Volume 183, Issue 14, Page 3935-3949, July 2026.
Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because of their association with counterculture movements and a perceived concern about harm through recreational use, and their consequent legal prohibition in the early 1970s.
Trevor Sharp, Aurelija Ippolito
wiley   +1 more source

Case Report: Four cases for cariprazine and alcohol use disorder. [PDF]

Front Psychiatry
Vicentic S.
europepmc   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, Volume 183, Issue 14, Page 3897-3919, July 2026.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Relationships of beta-blockers and anxiolytics intake and salivary secretion, masticatory performance and taste perception.

Archives of Oral Biology, 2010
L. F. de Matos, S. Pereira, E. Kaminagakura, L. Marques, C. V. Pereira, A. van der Bilt, L. J. Pereira   +6 more
semanticscholar   +1 more source

Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?

British Journal of Pharmacology, Volume 183, Issue 14, Page 4006-4021, July 2026.
Psychedelic drugs that activate 5‐HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics for treating psychiatric disorders has resurged recently and is well documented; less well recognised are their anti‐inflammatory properties. Growing evidence now demonstrates that psychedelics modulate immune
Omar Qureshi, Jamie Cowley, Ashley Pegg, Alison J. Cooper, John Gordon, Catherine A. Brady, Antonio Belli, Sam Butterworth, Rachel Upthegrove, Nick Andrews, Nicholas M. Barnes   +10 more
wiley   +1 more source

AI-driven European Retrospective Database Study to predict disease onset in patients with epilepsy and depression. [PDF]

BMJ Neurol Open
Ruggieri A, Leach JP, Alvarez-Baron E, Di Franco V, Benoist CC, Comandini A, Di Loreto G, Lovera A, Constandse T, Pili M, Gallinaro J, Farhadi Ghalati P, Bayard F, Raslan AS, O'Loughlin A, Vamosi B, Cattaneo A.   +16 more
europepmc   +1 more source